Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. NOVO
  4. NOVO — Januar 2025

NOVO — Januar 2025

Planlagt Fastgjort Låst Flyttet NOVO
233 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • StockBullS Offline
    StockBullS Offline
    StockBull
    wrote on sidst redigeret af
    #181

    Fed nyhed, så starter de vel nok snart produktion i Kalundborg. Måske inden for kommende 12 mdr

    1 Reply Last reply
    0
    • S Offline
      S Offline
      Sukkeralf
      wrote on sidst redigeret af
      #182

      fase 1/2 data

      1 Reply Last reply
      0
      • P Offline
        P Offline
        ProinvestorNEWS
        wrote on sidst redigeret af
        #183

        Sydbank om Novo: Fuldstændig fair kursreaktion på stærke vægttabsdata https://proinvestor.com/investornyt/1269139/sydbank-om-novo-fuldstaendig-fair-kursreaktion-pa-staerke-vaegttabsdata

        1 Reply Last reply
        0
        • P Offline
          P Offline
          ProinvestorNEWS
          wrote on sidst redigeret af
          #184

          Novos markedsværdi steg 183 mia. kr. efter stærke fedmedata https://proinvestor.com/investornyt/1269198/novos-markedsvaerdi-steg-183-mia-kr-efter-staerke-fedmedata

          1 Reply Last reply
          0
          • K Offline
            K Offline
            koden
            wrote on sidst redigeret af
            #185

            endte "kun" 7% oppe

            1 Reply Last reply
            0
            • J Offline
              J Offline
              JKY_VH
              wrote on sidst redigeret af
              #186

              jeg hæfter mig ved "vendingen" og 7% er ikke dårligt

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JKY_VH
                wrote on sidst redigeret af
                #187

                detalje, der "blot gør dagens nye resultater endnu mere imponerende." https://www.shareholders.dk/nyhed/novo-aktien-i-markant-stigning-efter-nye-data?utm_source=Aktionærens Nyhedsbrev&utm_campaign=be4509cbe1-20-07-2024_COPY_01&utm_medium=email&utm_term=0_bfc53fad21-be4509cbe1-90602917

                1 Reply Last reply
                0
                • Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktørH Offline
                  Helge_LarsenPI-redaktør
                  wrote on sidst redigeret af
                  #188

                  Godmorgen 🙂

                  1 Reply Last reply
                  0
                  • R Offline
                    R Offline
                    Riis7
                    wrote on sidst redigeret af
                    #189

                    godmorgen:_)

                    1 Reply Last reply
                    0
                    • R Offline
                      R Offline
                      Riis7
                      wrote on sidst redigeret af
                      #190

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #191

                        Tak Riis7

                        1 Reply Last reply
                        0
                        • Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktørH Offline
                          Helge_LarsenPI-redaktør
                          wrote on sidst redigeret af
                          #192

                          Novo Nordisk’s Amycretin: A Glimpse into the Future of GLP-1 Weight Loss Treatments https://www.onthepen.com/post/novo-nordisk-s-amycretin-a-glimpse-into-the-future-of-glp-1-weight-loss-treatments?utm_campaign=e6280513-1189-4af4-8ad5-bb1922b1e58a&utm_source=so&utm_medium=mail&cid=713e80cd-1fa6-468e-90d7-68fd62c5df0e

                          1 Reply Last reply
                          0
                          • K Offline
                            K Offline
                            koden
                            wrote on sidst redigeret af
                            #193

                            Vi skal lige huske at studiet på Amycretin er et fase 1b/2a studie. Muligt de får lov at springe til fase 3. Men Cagrisema er vel stort set produktionsklar?

                            1 Reply Last reply
                            0
                            • S Offline
                              S Offline
                              Svend_Skriver
                              wrote on sidst redigeret af
                              #194

                              'Virker usandsynligt, at Novo Nordisk rammes af potentiel toldsats, siger analytiker' Søren Løntofts vurdering. NB: Indslaget fra 22/1 2025.
                              https://nyheder.tv2.dk/live/udland/2025-01-18-trump-i-det-hvide-hus?entry=87246090-06e0-4e85-b939-4c550c316c73

                              1 Reply Last reply
                              0
                              • K Offline
                                K Offline
                                koden
                                wrote on sidst redigeret af
                                #195

                                nej medmindre at trump vil presse DK om Grønland. Men de har jo brug for wegovy, så næppe.

                                1 Reply Last reply
                                0
                                • J Offline
                                  J Offline
                                  JKY_VH
                                  wrote on sidst redigeret af
                                  #196

                                  Fra Reuters "Veru said on Monday its
                                  experimental drug, in combination with Novo Nordisk's
                                  weight-loss treatment Wegovy, helped preserve muscle in older
                                  patients with obesity, meeting the main goal of a mid-stage
                                  study.
                                  The study was testing Veru's oral drug, enobosarm, in
                                  patients aged 60 and above. The drug targets androgen hormones,
                                  which play a role in body development and reproductive health.
                                  Patients who received the drug in combination with
                                  Wegovy lost 71% less lean muscle on average than

                                  1 Reply Last reply
                                  0
                                  • J Offline
                                    J Offline
                                    JKY_VH
                                    wrote on sidst redigeret af
                                    #197

                                    those who
                                    received Wegovy alone, the company said."

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #198

                                      "Veru said on Monday its
                                      experimental drug, in combination with Novo Nordisk's
                                      weight-loss treatment Wegovy, helped preserve muscle in older
                                      patients with obesity, meeting the main goal of a mid-stage
                                      study."

                                      1 Reply Last reply
                                      0
                                      • Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktørH Offline
                                        Helge_LarsenPI-redaktør
                                        wrote on sidst redigeret af
                                        #199

                                        Novo sagsøgt af investor efter data fra fedmeforsøg med Cagrisema https://proinvestor.com/investornyt/1270031/novo-sagsogt-af-investor-efter-data-fra-fedmeforsog-med-cagrisema

                                        1 Reply Last reply
                                        0
                                        • StockBullS Offline
                                          StockBullS Offline
                                          StockBull
                                          wrote on sidst redigeret af
                                          #200

                                          Trump truer big pharma: https://x.com/FinanceLancelot/status/1884023740826280053

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper